Actavis (NYSE: ACT) a global, integrated specialty pharmaceutical company

Country websites Country websites
  • Australia (Ascent)
  • Australia (Spirit)
  • Austria
  • Belgium
  • Bosnia and Herzegovina
  • Bulgaria
  • Brazil
  • Canada (Cobalt)
  • Canada (Watson)
  • China
  • Czech Republic
  • Denmark
  • Finland
  • France (Arrow)
  • Germany
  • Germany (Arrow)
  • Greece (Alet)
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Ireland
  • Ireland (Arrow)
  • Japan
  • Lithuania
  • Luxemburg
  • Malaysia (DHA)
  • Malta
  • Mongolia
  • New Zealand (Arrow)
  • Netherlands
  • Norway
  • Poland
  • Poland (Arrow)
  • Portugal
  • Romania
  • Russia
  • Serbia
  • Singapore (DHA)
  • Spain
  • Sweden
  • Sweden (Arrow)
  • Switzerland
  • Turkey
  • Ukraine
  • United Kingdom
  • United Kingdom (Arrow)
  • United Kingdom (Eden)

  • About Actavis
    • Company Profile
    • CEO Message
    • Mission / Culture
    • Executive Leadership
    • Global Locations
      • Facilities
      • Commercial
        • Americas
          • Europe
            • Asia Pacific
      • Global Business
        • Actavis Pharma
          • North America
          • Europe
          • Asia & MEA
        • Actavis Specialty Brands
          • United States
          • Canada & LATAM
          • Biosimilars
        • Distribution
          • Anda
          • PractRx
          • Intellogics
      • Products
        • R&D
          • R&D Sites
          • Generics R&D
          • Biosimilars R&D
          • Brands R&D
        • Therapeutic Classes
          • Generics
          • Biosimilars
          • Brands
        • Drug Safety
        • Quality
        • U.S. Product Database
      • Investors
        • Press Releases
        • Financial Information
          • SEC Filings
          • Annual Reports
          • Quarterly Results
          • 2013 Proxy Materials
          • Corporate Fact Sheet
        • Corporate Governance
          • Executive Officers and Directors
          • Committee Composition
          • Committee Charters
          • Code of Conduct
          • Governance Guidelines
          • Insider Transactions
          • Actavis Compliance Program
        • Events and Presentations
        • Stock Information
          • Stock Quote
          • Stock Chart
          • Historical Price Lookup
          • Investment Calculator
        • Shareholder Services
          • FAQs
          • Information Requests
          • E-mail Alerts
        • Analyst Coverage
      • Responsibility
        • Environmental
          • Employees
          • Facilities & Manufacturing
          • Partners
        • Community
        • Media
          • Corporate Profile
          • Press releases
            • Resources
          • Careers
            • Working at Actavis
              • Culture
              • Benefits
            • Career Opportunities
            • University
              • On-Campus Recruiting
              • Internships & Programs
                • Recent Graduates
                • Applying to Actavis in the US
            • Contact Us

            Watson and Actavis are now Actavis learn more

            Recent News

            • 14/05/2013 Announcement Under Irish Takeover Rules Relevant Securities in Issue
            • 13/05/2013 Actavis' NDA for Progestin-Only Patch Accepted for Filing by FDA
            • 13/05/2013 Actavis Cancels Presentation at Bank of America Merrill Lynch Healthcare...
            • We are the New ActavisWe are the New Actavis

              We are the New Actavis

            • A Global Leader in GenericsA Global Leader in Generics

              A Global Leader in Generics

            • Aggressively Expanding Global BrandsAggressively Expanding Global Brands

              Aggressively Expanding Global Brands

            • Building a Foundation in BiosimilarsBuilding a Foundation in Biosimilars

              Building a Foundation in Biosimilars

            • Enhancing Customer and Shareholder ValueEnhancing Customer and Shareholder Value

              Enhancing Customer and Shareholder Value

            • NYSE:ACTNYSE:ACT

              NYSE:ACT

            Act One

            NYSE

            ACT:
            -
            U.S. Product Dayabase

            Product Database

            Commitment to Quality

            Copyright 2013 Actavis. All rights reserved. Legal/Copyright Disclaimer Privacy Policy Sitemap Compliance Business Development Stock quote feed is powered by EDGAR Online. Intraday data is at least 20-minutes delayed. All times are EDT.